|
Back
to the articles...
Synonyms EGD; Esophagogastroduodenoscopy; Esophagoscopy (if
Esophagus Alone Studied); Peroral Endoscopy; Upper Endoscopy
Procedure Commonly Includes Direct visual
examination of the upper gastrointestinal tract by means of a flexible fiberoptic
endoscope. Typically, the procedure is carried out on an awake, but sedated, patient
either in a specially equipped endoscopy suite or at the bedside in an intensive care
unit. The endoscope is advanced (by mouth) through the oropharynx, esophagus, stomach, and
duodenum. Important anatomic landmarks are identified and mucosal surfaces are examined
for suspicious lesions such as ulcers, erosions, polyps, strictures, malignancies,
varices, bleeding sites, etc. Biopsy specimens are easily obtained, and may be sent for
histopathology, cytology, and/or microbiological culture. Other minor operative procedures
may be performed utilizing the standard endoscope, including polypectomy, cytologic
brushings, sclerotherapy of esophageal varices, extraction of foreign bodies, and
electrocautery of bleeding sites.
Indications The precise indications for
esophagogastroduodenoscopy (EGD) are still evolving and physician discretion still plays a
major role.1,2 Practice patterns amongst physicians vary considerably.
Controversy exists regarding the use of EGD as a first-line diagnostic procedure for
suspected upper GI disease. Some clinicians have virtually abandoned the standard upper GI
barium swallow in favor of endoscopy. This approach addresses the problem of the
false-negative upper GI series but is quite expensive and not without risk. In each case,
a number of factors must be individually weighed, such as the risk of complications, cost
of the procedure (versus upper GI series), expected diagnostic benefits, and probability
of a normal (negative) examination. Diagnostic indications may be grouped as follows. High
yield indications:
|
acute
upper GI bleeding, to establish the exact location of hemorrhage prior to endoscopic
cautery, surgery, etc |
|
dysphagia,
especially if esophageal strictures or ulcerations are seen on a previous upper GI series.
Note that EGD may still be indicated if the barium swallow is normal but clinical
suspicion of esophageal disease remains high |
|
dyspepsia,
if refractory to standard medical antireflux therapy. EGD is also indicated whenever a
surgical antireflux procedure is planned |
|
odynophagia, when inflammation or infection is clinically suspected, especially if
esophagitis from Candida, cytomegalovirus, or herpes simplex virus is likely |
|
surveillance endoscopy for known premalignant conditions, such as Barrett's esophagus,
lye-induced strictures, Plummer-Vinson syndrome |
|
abnormalities seen on upper GI series which require visual confirmation and tissue biopsy
(eg, polyps, gastric ulcers, redundant gastric folds, strictures) |
|
suspected
gastric outlet obstruction |
Lower yield indications (procedure not always appropriate):
|
atypical
chest pain |
|
abdominal
pain of unknown etiology |
|
routine,
uncomplicated cases of gastroesophageal reflux |
|
uncomplicated cases of duodenal ulcer demonstrated by upper GI series |
Therapeutic indications for EGD are numerous and include:
|
sclerotherapy of bleeding esophageal varices |
|
management
of upper GI bleeding using electrocautery, photocoagulation, etc |
|
laser
ablation of esophageal cancer |
|
endoscopic
placement of esophageal stints |
|
placement
of permanent feeding tubes under endoscopic guidance (PEG tubes) |
|
dilatation
of esophageal strictures |
|
polypectomy |
|
dissolution of bezoars |
Contraindications
|
acute
myocardial infarction |
|
hypoxemia
with respiratory distress |
|
hypotension and shock, regardless of etiology |
|
massive
upper GI bleeding with hypotension where emergency surgery is clearly appropriate (EGD may
needlessly delay surgery and visualization is often obscured by copious amounts of blood.)
|
|
uncontrolled hypertension |
|
patient
refusal |
Relative contraindications (high risk situations) include:
|
noncorrectable coagulopathy |
|
recent
myocardial infarction (within weeks) |
|
severe
coronary artery disease |
|
recent
upper GI tract surgery where anastomotic sites may still be "fresh" |
|
active
peritonitis |
|
subluxation or instability of the cervical spine |
|
anterior
cervical spine osteophytes |
|
perforated
viscus |
|
Zenker's
diverticulum (possibly) |
Patient Preparation Technique and risks of the
procedure are explained to the patient and informed consent is obtained. In some medical
centers formal consultation with gastroenterology staff is mandatory before obtaining an
EGD. In other institutions procedure is arranged directly with the endoscopy scheduling
desk by the primary physician. EGD may be performed on either inpatients or outpatients.
Customarily, inpatients are examined briefly by the endoscopist (or his representative)
the day prior to EGD in order to review details of the case, write orders, and answer
patient questions. It should be emphasized that patients frequently experience
apprehension and fear regarding choking on the endoscope. Careful and thoughtful
reassurances from the medical team may be quite effective in allaying these anxieties.
Patient is kept strictly NPO for 8 hours prior to EGD. If a morning procedure is planned,
patient is NPO after midnight. If EGD is scheduled for later in the afternoon, some
centers allow a light breakfast that morning. Daily medications are permitted with small
sips of water. Medicines which potentially interfere with visualization of the mucosa,
such as antacids or CarafateŽ, should be discontinued beforehand. If a tissue biopsy is
anticipated, aspirin products, and nonsteroidal agents are discontinued well in advance
(at least 5 days for aspirin). If gastric outlet obstruction is clinically suspected,
nasogastric suction is performed prior to EGD in order to remove retained luminal
contents. This also applies to the patient with known or suspected impairment of gastric
motility. For inpatients, dentures are removed and patient is transported to endoscopy
suite on a cart, along with medical chart and relevant x-rays. For outpatients,
arrangements for driver transportation home must be made in advance by patient, since
driving is not permitted after procedure. Once patient is in the procedure room, baseline
vital signs are obtained (pulse, blood pressure, etc). Intravenous sedation is routinely
given, commonly diazepam (or another short-acting benzodiazepine) and meperidine several
minutes prior to examination. A topical anesthetic agent such as CetacaineŽ spray
(benzocaine and tetracaine hydrochloride) is often applied to the pharynx.
Aftercare Immediately postprocedure the patient is observed
in the recovery area. Vital signs are usually recorded at least once, and prn in the
"high risk" patient. If no complications have occurred and sedation has worn
off, patient may be discharged from the testing area. A normal diet may be resumed once
gag reflex has returned. Driving is not allowed due to residual sedative effects.
Complications Morbidity and mortality of upper
endoscopy is relatively low, but should not be overlooked. Statistics compiled from
several large clinical series suggest an incidence of adverse outcomes of 0.1% to 0.2%.
Death has been reported between 0.14-0.65/1000 endoscopies. Major complications, as
described by Shamir and Schuman, are as follows.3
|
Perforation of esophagus or stomach: Up to 0.1% of all EGDs (some large centers report no
cases of perforation). The upper esophagus above the cricopharynx appears most vulnerable.
Other risk factors are esophageal cancer, strictures, or cervical osteophytes. |
|
Bleeding:
Considered rare even after biopsies, at 0.3/1000 cases. In most cases, bleeding is not due
to a coagulation defect, rather it results from biopsy of friable tissue. |
|
Cardiopulmonary complications: Significant cardiac arrhythmias are distinctly unusual. If
a Holter monitor is placed, transient rhythm disturbances such as sinus tachycardia,
premature ventricular contractions (PVCs), premature atrial contractions (PACs), and
rarely ischemic changes may be recorded in <22% of cases. Few adverse clinical outcomes
have been reported. |
Other complications include the following.
|
Pulmonary
aspiration has been estimated at 0.8/1000 cases, but carries a mortality rate of 10%.
Prout demonstrated that some degree of aspiration occurs in as many as 25% of cases, using
iodinated oil as a marker. No cases of clinical pneumonia developed.4 |
|
Toxicity
of premedications: Minor complications are fairly common but usually inconsequential.
Diazepam may cause a local phlebitis and meperidine may induce transient nausea. More
importantly, the patient with severe COPD or liver cirrhosis may experience respiratory
depression from this combination. In one series from England, 0.67 out of 1000 EGDs were
followed by respiratory arrest requiring mechanical ventilation.5 |
|
Infection:
Prospective studies have shown a bacteremia rate of 3% to 8% (positive blood cultures).
Some centers routinely use antibiotic prophylaxis in patients with valvular heart disease,
although the risk of endocarditis is probably extremely low.6 |
|
Miscellaneous: Parotid swelling, abdominal pain from air insufflation, transient
megacolon, transient fever with pulmonary infiltrates (following sclerotherapy of
varices). |
Equipment The fiberoptic endoscope has replaced the rigid
endoscope as the instrument of choice. This device has a length of approximately 1200 mm
and diameter of 9.5-12.5 mm. The instrument shaft is composed of numerous specialized
glass fibers (>30,000) which allow the transmission of light down the length of each
thin fiber with minimal distortion. The multiple fiberoptic images are integrated at the
proximal eyepiece unit, by means of a complex system of lenses. The endoscopist thus views
a reconstructed, mosaic image at the proximal eyepiece (similar to a television image).
Also within the instrument shaft are several separate channels designed for passage of
optional devices such as biopsy forceps, polyp snare, cytology brush, cautery or laser
device, and suction. Air may also be introduced for insufflation of the stomach. For
clearing of debris from the viewing area, a jet stream of water from a separate reservoir
can be flushed through one channel. At the head or handle of the endoscope are two control
devices ("wheels") which maneuver the instrument tip as it is advanced, an
up-down angle wheel (deflection of almost 180°) and a right-left angle wheel (deflection
of 100°). The instrument head is connected with a separate cold light source (usually a
halogen lamp) by means of a cable comprised of incoherent fiberoptic bundles (the
"umbilical cord"). The water feed tank and automatic suction box also attach to
this cable. Optional accessories include an additional eyepiece for simultaneous viewing
by a second operator (the "teaching head"), an ultrasound probe for real time
imaging of the stomach wall, pancreas, etc, and photographic or videotape recording
devices.
Technique Performed only by an experienced
gastroenterologist in a properly equipped endoscopy suite. At times, it may be necessary
to carry out this procedure in an emergency room or ICU bed. Following sedation, patient
is placed in the left lateral decubitus position (although successful intubation is
possible in other positions). A hollow mouthpiece is inserted to protect the patient's
teeth and facilitate instrument passage. The endoscope is slowly advanced orally and is
"swallowed" by the patient. Once past the cricopharyngeal region the instrument
is guided only under direct visualization. An important landmark is the Z-line at the
gastroesophageal junction, approximately 40 cm from the teeth. The tip is then advanced
into the cardia, with gentle insufflation of air. The various portions of the stomach are
inspected - cardia, fundus, greater and lesser curvature, antrum. Following thus, the tip
is then passed through the pylorus, into the duodenal bulb, and sometimes as far as the
descending portion of the duodenum. Mucosal surfaces are reinspected as the instrument is
withdrawn. Biopsies, cytologic brushings, polypectomy, cauterization of bleeding lesions,
etc, are performed as indicated. Sclerotherapy of esophageal varices is not considered
part of the routine EGD. This is a separate therapeutic procedure requiring additional
equipment and somewhat more involved patient preparation.
Specimen All biopsy specimens and cytologic brushings are
sent to the Pathology Laboratory without delay in appropriate containers and fixatives.
Tissue for Gram's stain, KOH prep, and culture should be sent in sterile containers
without fixative to the Microbiology Laboratory. The details of proper specimen
collection, fixation, and transportation are usually supervised by the gastroenterology
team.
Turnaround Time Final report on biopsy specimen
histopathology is given within 2-3 days. Gram's stain and KOH prep are known immediately
(within minutes if necessary) but culture results may require several days (or more than 1
week if viral culture requested).
Normal Findings No upper GI tract pathology
encountered. Preliminary written report on endoscopic findings is completed immediately by
gastroenterology staff and placed in medical chart before the patient is discharged from
the endoscopy suite. A final typewritten report is added to the chart in 5-7 days. In
general, the endoscopist comments in detail on all findings, normal and abnormal, and
concludes with an overall clinical impression.
Critical Values No grading schemes or numerical
"cutoffs" per se. Subjective interpretation of visual findings by an experienced
gastroenterologist constitutes the data base. Important aspects of the endoscopic
examination frequently commented upon include:
|
location
of the Z-line |
|
presence
or absence of hiatal hernia |
|
appearance
of mucosal surfaces, with attention to ulcerations, erosions, strictures, masses, streaks,
polyps, Barrett's-type epithelium, redundant tissue, etc |
|
location
and appearance of bleeding site(s) or varices |
|
abnormalities in tone (spasm) of the lower esophageal sphincter or pylorus |
|
miscellaneous abnormalities |
|
operative
procedure(s) performed during endoscopy |
|
complications |
|
technical
adequacy of the study |
In some centers, instant photographs of suspicious lesions are taken during endoscopy
and included in the medical chart. In our institution, many endoscopic examinations are
recorded on real time videotape for later review by the referring physician and
endoscopist.
Limitations Quality of study and its interpretation are
highly dependent on the expertise of the endoscopist. Recognition of subtle abnormalities
and visualization of all portions of the upper GI tract require a high degree of clinical
competence. A variety of technical factors may lead to a suboptimal study. Endoscopists
refer to "blind spots" - regions difficult to visualize in most cases - which
include the superior aspect of the duodenal bulb, portions of the fundus, and the lesser
curvature below the incisura. Active uncontrolled bleeding, retained blood in the stomach,
and retained food or antacids may also lead to an inadequate study. EGD should not be used
for the diagnosis of esophageal motility disorders. The procedure of choice for this
entity is esophageal manometry. Similarly, EGD is not a first-line test for the diagnosis
of reflux esophagitis (although characteristic histologic changes may be found on mucosal
biopsy).
Footnotes
|
1. Gibb SP, Laney JS, and Tarshis AM, "Use of Fiberoptic Endoscopy in
Diagnosis and Therapy of Upper Gastrointestinal Disorders,"Med Clin North Am,
1986, 70:1307-24. |
|
2. Grossman MB, "Gastrointestinal Endoscopy,"Ciba Found Symp,
1980, 32:2-36. |
|
3. Shahmir M and Schuman BM, "Complications of Fiberoptic
Endoscopy,"Gastrointest Endosc, 1980, 26:86-91. |
|
4. Prout BI and Metreweli C, "Pulmonary Aspiration After
Fiberendoscopy of the Upper Gastrointestinal Tract,"Br Med J [Clin Res], 1972,
4:269-71. |
|
5. Schiller KFR, Cotton PB, and Salmon PR, "The Hazards of Digestive
Fiberendoscopy: A Survey of British Experience,"Gut, 1972, 13:1027. |
|
6. Durack DT, "Prophylaxis of Infective Endocarditis,"Principles
and Practices of Infectious Diseases, 3rd ed, Chapter 63, Mandell GL, Douglas RG, and
Bennett JE, eds, New York, NY: Churchill-Livingstone, 1990, 716-21. |
References
|
Botet JF and Lightdale C, "Endoscopic Sonography of the Upper
Gastrointestinal Tract,"AJR, 1991, 156(1):63-8. |
|
Kahn KL, Kosecoff J, Chassin MR, et al, "The Use and Misuse of Upper
Gastrointestinal Endoscopy,"Ann Intern Med, 1988, 109(8):664-70. |
|
Morrissey JF and Reichelderfer M, "Medical Progress: Gastrointestinal
Endoscopy,"N Engl J Med, 1991, 325(16):1142-9. |
|
Rubin CE, Silverstein FE, and McDonald GB, "Indications for
Fiberoptic Endoscopy,"Viewpoints Digestive Dis, 1978, 10:5. |
|
Schrock TR, "Complications of Gastrointestinal Endoscopy,"Gastrointestinal
Disease: Pathophysiology, Diagnosis, and Management, 4th ed, Chapter 13, Sleisenger MH
and Fordtran JS, eds, Philadelphia, PA: WB Saunders Co, 1989, 216-21. |
|
Schuman BM, "Upper Gastrointestinal Endoscopy,"Bockus
Gastroenterology, 4th ed, Chapter 41, Berk JE, ed, Philadelphia, PA: WB Saunders Co,
1985, 564-80. |
|
|